The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Naoki Terasaka
Pharmacology and Molecular Biology Research Laboratories
Sankyo Co.
Ltd., 1-2-58 Hiromachi
Shinagawa-ku
Japan
Name/email consistency: high
- ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice. Terasaka, N., Miyazaki, A., Kasanuki, N., Ito, K., Ubukata, N., Koieyama, T., Kitayama, K., Tanimoto, T., Maeda, N., Inaba, T. Atherosclerosis (2007)
- Liver X receptor agonists inhibit tissue factor expression in macrophages. Terasaka, N., Hiroshima, A., Ariga, A., Honzumi, S., Koieyama, T., Inaba, T., Fujiwara, T. FEBS J. (2005)
- T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. Terasaka, N., Hiroshima, A., Koieyama, T., Ubukata, N., Morikawa, Y., Nakai, D., Inaba, T. FEBS Lett. (2003)
